BIEL- Bioelectronics

Bioelectronics Website
I've been watching this since .0089, started buying at .028, and have kept buying, at .05 and .074 as well. I missed the drop to the .04s recently but if it goes there again, I will increase my position.

BIEL makes pain management patches. BIEL is a family managed company and as such, lacks the financial clarity other companies have. BIEL was heavily in debt until recently, when they converted shares to cover debt. so they now have a whopping 1 billion shares.

On their most recent conference call, they shared that:
1. They recently filed 510K applications with the FDA for their pain management patches.
2. They have managed to wipe out most of their debt (see above reference to 1 billion shares)
3. They are marketing their product in China, Europe, and Canada.
4. They have hired two brand managers who are hoping to help them change the image of pain management from OTC medications like Tylenol or Advil with organ risks to a more natural method, like their patches.
5. They have extremely positive recent clinical trial data- the patches worked very well and had no adverse side effects .
6. They have had so many requests for trials, they can not stage any more new clinical trials at this time.
7. They are hoping to get approval for muscoloskeletal pain, post surgical pain, and menstrual pain.
8. They have filed to have their devices moved from Class III categorization (toughest to get approved) to Class II.

They are benefiting heavily from the FDA's announcement about limiting the dosage of acetameophin and the possible elimination of some narcotic painkillers.

A recent analyst report on value of the stock PPS places it between .30-.50 with FDA approvals.

OTHER NEWS:
An Extreme Medical Device Trade
BIEL Receives Patent
An Opportunity in Uncertainty
BioElectronics Corp.'s Patented ActiPatch® Therapy and AllayTM Patches Are Safe and Effective Alternatives to Acetaminophen
A Pain Free Breakout?